Skip to main content

Have you heard about the Telehealth Services Benefit Program?

Receive access to FREE dental and vision coverage, an Employee Assistance Program (EAP), unlimited telemedicine calls, ten teletherapy sessions and an optional Whole Life insurance policy simply for being an active member of The Nevada Registry! (Must be working in a child care center or other Early Childhood-related program in Nevada to qualify.)

Click here for more information!

On May 17, 2022, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine. This amendment authorizes administration of a single booster dose to children ages five through 11 years old after completion of a primary series with the Pfizer-BioNTech COVID-19 vaccine. On May 19, 2022, the Advisory Committee on Immunization Practices (ACIP) met and voted to approve a recommendation stating, “A single Pfizer-BioNTech COVID-19 vaccine booster dose is recommended for persons ages 5-11 years at least five months after the primary series, under the FDA’s Emergency Use Authorization.”

A technical bulletin, published on May 25, 2022, by the Nevada Department of Health and Human Services, summarizes the recent Pfizer-BioNTech COVID-19 vaccine booster dose recommendation for children. Children eligible to receive the recommended Pfizer-BioNTech COVID-19 vaccine booster dose include:

  • Any individual ages 5 through 11 years old, at least five months after completion of a two-dose Pfizer-BioNTech COVID-19 vaccine primary series; and
  • Any moderately to severely immunocompromised individual ages 5-11 years old, at least three months after completion of a three dose Pfizer-BioNTech COVID-19 vaccine primary series.

Full details are available in the most recent technical bulletin on the web page linked here.

For more updates about medical and health-related facility licensure, visit the
Bureau of Health Care Quality and Compliance blog site.